Invention Grant
- Patent Title: Compositions and methods for treating IgE-mediated disorders
- Patent Title (中): 用于治疗IgE介导的病症的组合物和方法
-
Application No.: US12562088Application Date: 2009-09-17
-
Publication No.: US08435517B2Publication Date: 2013-05-07
- Inventor: John R. Desjarlais , Seung Y. Chu , Holly M. Horton , Matthew J. Bernett
- Applicant: John R. Desjarlais , Seung Y. Chu , Holly M. Horton , Matthew J. Bernett
- Applicant Address: US CA Monrovia
- Assignee: Xencor, Inc.
- Current Assignee: Xencor, Inc.
- Current Assignee Address: US CA Monrovia
- Agency: Morgan Lewis & Bockius LLP
- Agent Robin M. Silva, Esq.; Ada O. Wong, Esq.
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
The present invention relates to immunoglobulins that bind IgE and FcγRIIb with high affinity, said compositions being capable of inhibiting cells that express membrane-anchored IgE. Such compositions are useful for treating IgE-mediated disorders, including allergies and asthma.
Public/Granted literature
- US20100080814A1 NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS Public/Granted day:2010-04-01
Information query
